We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Angiotensin 1 (Human) is the precursor to the vasoconstrictor peptide angiotensin II, cleaved by the angiotensin-converting enzyme (ACE).
CAT No: R1197
CAS No: 484-42-4
Synonyms/Alias: ANGIOTENSIN I;484-42-4;Proangiotensin;Pepsitensin;Angiotensin I (human);Angiotensin I (human, mouse, rat);Human angiotensin I;Angiotensin I, ile(5)-;5-Ile-angiotensin I;Angiotensin I (rat);Angiotensin I (mouse);9041-90-1;CHEBI:2718;Angiotensin 1 Human;Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu;L-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanyl-L-histidyl-L-leucine;Angiotensin 1 (Human);Angiotensins; Angiotonin;AC1MIWSO;(Ile5)-Angiotensin I;(Ile5)-Ang I;5-Isoleucine-angiotensin I;Angiotensin I 5-isoleucine;UNII-9C880YQG7C;5-L-Isoleucine-angiotensin I;Angiotensin I, isoleucine(5)-;MFCD00167405;DRVYIHPFHL;Angiotensin I (Callithrix jacchus gene angt);9C880YQG7C;CHEMBL262670;Angiotensin I, 5-L-isoleucine-;DTXSID80866222;D-R-V-Y-I-H-P-F-H-L;HY-P1032;AKOS024456668;CS-7599;FA73185;NCGC00167129-01;L-Leucine, N-(N-(N-(1-(N-(N-(N-(N-(N2-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanyl)-L-histidyl)-;NS00074072;C00873;G12434;Q32039285;L-Asp-L-Arg-L-Val-L-Tyr-L-Ile-L-His-L-Pro-L-Phe-L-His-L-Leu;(2S)-2-[(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-AMINO-3-CARBOXYPROPANAMIDO]-5-CARBAMIMIDAMIDOPENTANAMIDO]-3-METHYLBUTANAMIDO]-3-(4-HYDROXYPHENYL)PROPANAMIDO]-3-METHYLPENTANAMIDO]-3-(1H-IMIDAZOL-4-YL)PROPANOYL]PYRROLIDIN-2-YL]FORMAMIDO}-3-PHENYLPROPANAMIDO]-3-(1H-IMIDAZOL-4-YL)PROPANAMIDO]-4-METHYLPENTANOIC ACID;L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanyl-L-histidyl-L-leucine;Leucine, N-(N-(N-(1-(N-(N-(N-(N-(N2-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-3-phenylalanyl)-L-histidyl)-, L-;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C62H89N17O14 |
M.W/Mr. | 1296.5 |
Sequence | One Letter Code:DRVYIHPFHL Three Letter Code:H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH |
Source# | Synthetic |
InChI | InChI=1S/C62H89N17O14/c1-7-35(6)51(78-56(87)44(25-37-17-19-40(80)20-18-37)74-58(89)50(34(4)5)77-53(84)42(15-11-21-68-62(64)65)71-52(83)41(63)28-49(81)82)59(90)75-46(27-39-30-67-32-70-39)60(91)79-22-12-16-48(79)57(88)73-43(24-36-13-9-8-10-14-36)54(85)72-45(26-38-29-66-31-69-38)55(86)76-47(61(92)93)23-33(2)3/h8-10,13-14,17-20,29-35,41-48,50-51,80H,7,11-12,15-16,21-28,63H2,1-6H3,(H,66,69)(H,67,70)(H,71,83)(H,72,85)(H,73,88)(H,74,89)(H,75,90)(H,76,86)(H,77,84)(H,78,87)(H,81,82)(H,92,93)(H4,64,65,68)/t35-,41-,42-,43-,44-,45-,46-,47-,48-,50-,51-/m0/s1 |
InChI Key | ORWYRWWVDCYOMK-HBZPZAIKSA-N |
2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com